These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 1871523
1. [Spectacular effect of tiludronate in osteoporosis circumscripta cranii]. Renier JC, Audran M, Basle M, Morlock G. Rev Rhum Mal Osteoartic; 1991 Jan; 58(1):67-71. PubMed ID: 1871523 [No Abstract] [Full Text] [Related]
4. [Synthetic human calcitonin in Paget's disease of bone and osteoporosis (author's transl)]. Nuti R, Vattimo A. Dtsch Med Wochenschr; 1981 Jan 30; 106(5):149-52. PubMed ID: 6162631 [Abstract] [Full Text] [Related]
5. Relapse of osteoporosis circumscripta as a lytic ring after treatment of Paget's disease with intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate. Anderson DC, O'Driscoll JB, Buckler HM, Cantrill J, Brown JD. Br J Radiol; 1988 Nov 30; 61(731):996-1001. PubMed ID: 3208019 [Abstract] [Full Text] [Related]
9. [Circumscribed osteoporosis of the cranium and Paget's disease]. LOUYOT P, GAUCHER A, MATHIEU J. J Radiol Electrol Med Nucl; 1961 Oct 30; 42():576-8. PubMed ID: 14466860 [No Abstract] [Full Text] [Related]
20. Tiludronate for Bone Diseases. Proceedings of a satellite symposium of the XIIth International Conference on Calcium Regulating Hormones (ICCRH). Melbourne, Australia, 14 February 1995. Bone; 1995 Nov 10; 17(5 Suppl):471S-519S. PubMed ID: 8573420 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]